Skip to main content
OpenTrials
Completed

NCT Number: NCT05706064

Survey of COVID-19 Infection

Using online questionnaires, we will obtain data regarding COVID-19 infection and treatment, including incidence rate, hospitalization rate, severity of the infection, medications, mortality rate, etc, in both hospital and communities after the change of disease control policy in China.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • N/A

Exclusion criteria

  • N/A

Treatment and study plan

Primary outcomes

  1. All-cause mortality

    Time frame: 6 months

    Quickly obtain the all-cause mortality in patients with COVID-19

Secondary outcomes

  1. Incidence rate of COVID-19 infection

    Time frame: 6 months

    Incidence rate of COVID-19 infection

  2. Medication for COVID-19 treatment

    Time frame: 6 months

    Any medication for COVID-19 treatment

  3. Hospitalization rate due to COVID-19 infection

    Time frame: 6 months

    Hospitalization rate due to COVID-19 infection

  4. Severity of COVID-19 infection

    Time frame: 6 months

    severity of the COVID-19 infection

Sponsors and collaborators

Lead sponsor

Xijing Hospital

Other

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jan 31, 2023
Registry last updated
Jan 24, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.